Beta-thromboglobulin and platelet factor 4 plasma levels during haemodialysis: effect of indobufen.
The effect of a single dose of indobufen (100 mg i.v.) on the release of beta-thromboglobulin and of the platelet factor 4 was investigated during dialysis in 20 uraemic subjects by a within-subjects, single-blind, indobufen versus placebo study. Plasma levels were measured in baseline conditions and 15, 30, 60, 120 and 240 minutes after the beginning of dialysis. Pre-treatment with indobufen clearly inhibited beta-TG and PF 4 output. The difference from placebo was highly significant (p less than 0.01) from the 30-minute control up to the end of dialysis. No changes in platelet count before and after dialysis were observed.